CytoDyn Shares in Demand.SANTA FE Santa Fe, city, Argentina Santa Fe, city (1991 pop. 341,000), capital of Santa Fe prov., NE Argentina, a river port near the Paraná, with which it is connected by canal. , N.M. -- "The initial demand for our Company's shares exceeded our expectations," according to Corinne Allen, Vice President of Development at CytoDyn, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CYDY). "There have been times of the day when trading has been delayed due to the high demand for our stock," Ms. Allen explained. On its second day of trading, Friday, November 18, 2005, CytoDyn's shares closed at $2.10, up $1.45 on volume of 132,612. This past performance does not guarantee future results. CytoDyn is developing a family of targeted immune therapies for treating HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome . The Company's first product, Cytolin(R), has completed clinical trials for Phases I and II(a). However, the data have not yet been reviewed by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion